Already a subscriber? Make sure to log into your account before viewing this content. You can access your account by hitting the “login” button on the top right corner. Still unable to see the content after signing in? Make sure your card on file is up-to-date.

The United States has officially revoked and denied visas to some Indian business executives and corporate leaders over their alleged involvement in the trafficking of fentanyl precursor chemicals into the US.

Getting into it: The visa revocations were announced by the US Embassy in New Delhi, which stated that the actions were taken specifically against individuals and their family members due to their alleged roles in the illegal production and trafficking of fentanyl precursors. These chemicals, which are essential for creating fentanyl, were reportedly being manufactured or distributed to Mexico by companies linked to the affected Indian executives.

While the embassy did not disclose the identities of the individuals or the names of the companies involved, it made clear that such actors would now face heightened scrutiny and potential ineligibility for US travel.

According to the embassy, these visa measures are part of a broader effort by the Trump administration to protect Americans from the dangers posed by narcotics. Embassy Chargé d’Affaires Jorgan Andrews stressed that individuals and organizations involved in the trafficking of these drugs, as well as their immediate family members, would be subject to punitive consequences, including the denial of entry into the United States.

The embassy noted that it had a “steadfast commitment” to disrupting the international supply chains that feed the US fentanyl crisis. No comment from India yet.